HOME > ARCHIVE
ARCHIVE
- 1 in 5 Japanese May Suffer from Diabetes: Korosho Survey
September 1, 2003
- BI to Further Collaborate with Japanese Firms: Prof. Krebs
September 1, 2003
- REGULATORY NEWS IN BRIEF
September 1, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 1, 2003
- ON THE MOVE
September 1, 2003
- Dainippon to Promote Better Cancer Pain Management
September 1, 2003
- Don Quijote to Provide Free OTC Drugs in Late Night Emergencies
September 1, 2003
- Merck & Co. Determined to Acquire All Shares of Banyu
September 1, 2003
- Anti-fatigue Food, Drug Development Project to Start from October: Soiken
September 1, 2003
- WORLD NEWS IN BRIEF
August 25, 2003
- BULLETIN
August 25, 2003
- Effects of Triptan-type Migraine Drugs Differ by Patient
August 25, 2003
- BUSINESS NEWS IN BRIEF
August 25, 2003
- JPMA's R&D Committee to Focus on Pharmacogenomics: New Chairman
August 25, 2003
- Yonyaku to Bolster Alliance with Nakazawa Ujike
August 25, 2003
- NEW PRODUCTS
August 25, 2003
- API to Expand Contract Mfg of Investigational, Bulk Drugs
August 25, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 25, 2003
- Livalo to Drive Kowa's Growth
August 25, 2003
- Annual Financial Results
August 25, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
